iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionBrandywine Oak Private Wealth Llc
Latest Disclosed Ownership2,775 shares
Latest Disclosed Value $ 468,703
Brandywine Oak Private Wealth Llc reports 4.44% decrease in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 20, 2026 - Brandywine Oak Private Wealth Llc filed a 13F-HR form disclosing ownership of 2,775 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $468,703 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 2,904 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -4.44% during the quarter. The current value of the position is $363,664 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-20 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,775 -129 -4.44 469 -4.49 0.0394
2026-02-03 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,904 -65 -2.19 490 14.49 0.0411
2025-10-30 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,969 -145 -4.66 429 8.63 0.0372
2025-07-24 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,114 -237 -7.07 394 -7.94 0.0365
2025-05-07 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,351 -75 -2.19 429 -5.31 0.0420
2025-01-27 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,426 -143 -4.01 453 -12.91 0.0443
2024-11-07 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,569 -26 -0.72 520 5.27 0.0503
2024-07-30 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,595 -412 -10.28 493 -10.20 0.0507
2024-05-07 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,007 -143 -3.45 550 -2.49 0.0573
2024-02-05 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,150 -1,016 -19.67 564 -10.78 0.0626
2023-11-14 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,166 -351 -6.36 632 -9.86 0.0741
2023-08-11 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,517 -580 -9.51 700 -11.05 0.0784
2023-05-10 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 6,097 -119 -1.91 787 -3.55 0.0919
2023-02-06 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 6,216 -1,458 -19.00 816 -9.03 0.1015
2022-11-14 2022-09-30 13F ISHARES TR ISHARES BIOTECH ISHARES BIOTECH 464287556 7,674 -2,077 -21.30 897 -21.80 0.1218
2022-07-22 2022-06-30 13F ISHARES TR ISHARES BIOTECH ISHARES BIOTECH 464287556 9,751 -828 -7.83 1,147 -16.76 0.1468
2022-05-02 2022-03-31 13F ISHARES TR ISHARES BIOTECH ISHARES BIOTECH 464287556 10,579 -309 -2.84 1,378 -17.14 0.1576
2022-02-07 2021-12-31 13F ISHARES TR ISHARES BIOTECH ISHARES BIOTECH 464287556 10,888 -80 -0.73 1,663 -6.20 0.1816
2021-10-18 2021-09-30 13F ISHARES TR ISHARES BIOTECH ISHARES BIOTECH 464287556 10,968 -24 -0.22 1,773 -1.39 0.2059
2021-08-09 2021-06-30 13F ISHARES TR ISHARES BIOTECH ISHARES BIOTECH 464287556 10,992 682 6.61 1,798 15.85 0.2099
2021-05-06 2021-03-31 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 10,310 -102 -0.98 1,552 -1.59 0.2286
2021-02-08 2020-12-31 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 10,412 -818 -7.28 1,577 3.75 0.2404
2020-10-16 2020-09-30 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 11,230 780 7.46 1,520 6.07 0.2541
2020-08-06 2020-06-30 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 10,450 2,519 31.76 1,433 66.82 0.2547
2020-05-06 2020-03-31 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 7,931 166 2.14 859 -8.13 0.1773
2020-01-28 2019-12-31 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 7,765 -856 -9.93 935 9.10 0.1701
2019-10-30 2019-09-30 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 8,621 68 0.80 857 -8.15 0.1624
2019-07-22 2019-06-30 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 8,553 958 12.61 933 9.89 0.1865
2019-05-09 2019-03-31 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 7,595 31 0.41 849 17.92 0.1770
2019-02-14 2018-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY NASDAQ BIOTECH 464287556 7,564 7,564 720 0.1618
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.